Spellman G G, Macoviak J A, Gralnick H R
Blood. 1977 Oct;50(4):619-24.
The polymerization of thrombin and ancrod fibrin monomers was studied with a standardized technique that evaluated turbidity changes and protein incorporation into the clot. Ancrod fibrin monomers were found to polymerize more slowly and form less turbid clots (at identical protein concentrations). Changes in ionic strength and pH influences ancrod fibrin monomer polymerization to a greater extent than thrombin fibrin monomer polymerization. Benzyltriethylammonium chloride was shown to be a potent inhibitor of fibrin monomer polymerization, with a greater inhibitory effect on ancrod fibrin monomers than on thrombin fibrin monomers. The differences between ancrod and thrombin fibrin may play a role in the infrequent thrombotic complications reported with ancrod therapy.
采用一种标准化技术研究了凝血酶和安克洛纤维蛋白单体的聚合反应,该技术可评估浊度变化以及蛋白质掺入凝块的情况。研究发现,在相同蛋白质浓度下,安克洛纤维蛋白单体聚合速度更慢,形成的凝块浊度更低。离子强度和pH值的变化对安克洛纤维蛋白单体聚合的影响比对凝血酶纤维蛋白单体聚合的影响更大。苄基三乙基氯化铵被证明是纤维蛋白单体聚合的有效抑制剂,对安克洛纤维蛋白单体的抑制作用比对凝血酶纤维蛋白单体的抑制作用更强。安克洛和凝血酶纤维蛋白之间的差异可能与安克洛治疗中罕见的血栓形成并发症有关。